Brian Skorney

Stock Analyst at Baird

(1.18)
# 1663
Out of 5,255 analysts
140
Total ratings
43.48%
Success rate
4.00%
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
REGN Regeneron Pharmaceut...
Maintains: Neutral
759 652
602.46 8.22% 14 Apr 25, 2025
SLNO Soleno Therapeutics
Maintains: Outperform
72 102
73.32 39.12% 3 Mar 27, 2025
MIRM Mirum Pharmaceutical...
Maintains: Outperform
50 55
40.82 34.74% 5 Feb 27, 2025
DYN Dyne Therapeutics
Initiates Coverage On: Outperform
46
11.07 315.54% 1 Dec 13, 2024
BNTC Benitec Biopharma
Initiates Coverage On: Outperform
30
13.55 121.4% 1 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 5
0.4 1150% 4 Nov 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 20
5.59 257.78% 5 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
294 300
118.87 152.38% 15 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 193
60.46 219.22% 7 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
80 95
103.19 -7.94% 2 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
4.3 481.4% 1 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
32 10
2.33 329.18% 2 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
215 215
280.72 -23.41% 3 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
58 60
19.8 203.03% 2 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
157 180
106.69 68.71% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
28
3.69 658.81% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
52 62
32.42 91.24% 4 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 2
n/a n/a 4 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 39
9.15 326.23% 3 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
280 30
n/a n/a 2 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
63
37.56 67.73% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 173
n/a n/a 8 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 150
n/a n/a 1 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 18
n/a n/a 5 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
280 325
493.96 -34.21% 14 May 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 27
n/a n/a 1 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
43 55
n/a n/a 4 Oct 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
10
14.67 -31.83% 2 Aug 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
270
2.22 12062.16% 1 May 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 6
3.46 73.41% 1 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 100
n/a n/a 2 Aug 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
101
n/a n/a 3 Nov 1, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
600 300
1.66 17972.29% 2 May 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
33 0
n/a n/a 2 Jan 30, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 14, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Nov 29, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 8, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 2, 2016